Ethical Considerations in Expanded Access for Gene Therapy Companies

Time: 12:15 pm
day: Day Two


• Recognizing the ethical imperative for gene therapy companies to proactively develop expanded access policies
• Understanding obstacles developers face in providing expanded access to gene therapy products
• Recognizing that conditions with limited windows for treatment deserve special consideration in expanded access